US › Healthcare

Twist Bioscience Corp (TWST)

US · Healthcare · Diagnostics & Research

$99.44-1.60%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$110.7M
Revenue YoY
+19.3%
Net profit
$-44.0M
Profit YoY
-11.9%
EPS
$-0.60
EPS estimate
$-0.53
Net margin
-39.8%

EPS came in at -0.60 against a street estimate of -0.53 — a miss of 13.2%.

Key statistics

Market cap
$5.70B
Forward P/E
0.0
P/B
12.54
Book value
$7.32
EPS (TTM)
$-1.32
52-week high
$105.47
52-week low
$23.30
50-day MA
$83.51
200-day MA
$52.58
Beta
2.12

Analyst view

Analysts rate Twist Bioscience Corp a buy (9 buy, 2 hold, 1 sell out of 12) with an average price target of $92.50.

Shareholding

Insiders
1.19%
Institutions
128.78%

Largest institutional holders

FundStake
Artisan Partners Limited Partnership10.23%
ARK Investment Management LLC10.19%
BlackRock Inc8.92%
EdgePoint Investment8.64%
William Blair Investment Management, LLC8.46%
State Street Corp5.89%
Vanguard Portfolio Management, LLC4.25%
Vanguard Capital Management, LLC4.24%

Recent filings & reports

DocumentDate
Results announced · Q3 20262026-08-03
Quarterly report · Q1 20262026-05-04
Results announced · Q2 20262026-05-04
Company announcement · Q1 20262026-02-17
Shareholder vote results · Q1 20262026-02-06
Quarterly report · Q4 20252026-02-02
Proxy statement · Q1 20262026-01-06
Annual report FY20252025-11-17

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Twist Bioscience Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.